Fixed Phage secures further £1.5m investment to scale programmes in Animal, Veterinary and Human Health
Glasgow-based Biotechnology business, Fixed Phage, secures £1.5m follow-on investment to further scale development and commercialisation of bacteriophage technology in the fight against antimicrobial resistance. The latest funding round has seen current investors, including Scottish Enterprise and London Scottish Investment Partners...
